| 1. |
- Axaeus, Jennie, 1974-, et al.
(författare)
-
Portar till språk och litteratur : CSL 2007
- 2007
-
Bok (övrigt vetenskapligt/konstnärligt)abstract
- Språk och litteratur öppnar portar till nya världar. Detta var temat för 2007 års CSL-dag. I denna bok har vi samlat fjorton av bidragen som presenterades på konferensen, skrivna av forskare och studenter vid Karlstads universitet.Håller engelskan på att förstöra svenskan? Är dagens elever sämre på att skriva än ungdomarna var för tjugo år sedan? Skall vi ha en litteraturkanon i skolan - och läser eleverna över huvud taget böcker nu för tiden? Detta är några av de frågor som ställs i artiklarna där svaren kanske kan överraska.Andra artiklar handlar om hur man stimulerar elever till att läsa och skriva, problematiken när det gäller att undervisa i svenska som andraspråk och varför elever väljer - eller inte väljer - att studera något annat främmande språk än engelska. Porten kanske finns där - men den är inte alltid helt lätt att öppna!
|
|
| 2. |
- Brorsson, Anna Lena, 1964-, et al.
(författare)
-
Adolescents’ perceptions of participation in group education using the Guided Self-Determination-Young method : a qualitative study
- 2017
-
Ingår i: BMJ Open Diabetes Research & Care. - : BMJ. - 2052-4897. ; 5:1
-
Tidskriftsartikel (refereegranskat)abstract
- Objective Guided Self-Determination (GSD) is a person-centered communication and reflection method. Education in groups may have a greater impact than the content of the education, and constructive communication between parents and adolescents has been shown to be of importance. The purpose of this study was to describe adolescents’ perceptions of participation in group education with the Guided Self-Determination-Young (GSD-Y) method, together with parents, in connection with the introduction of continuous subcutaneous insulin infusion.Research design and methods In the present qualitative interview study, 13 adolescents with type 1 diabetes were included after completing a GSD-Y group education program in connection with the introduction of continuous subcutaneous insulin infusion at three hospitals located in central Sweden. The adolescents were interviewed individually, and qualitative content analysis was applied to the interview transcripts.Results Two categories that emerged from the analysis were the importance of context and growing in power through the group process. An overarching theme that emerged from the interviews was the importance of expert and referent power in growing awareness of the importance of self-management as well as mitigating the loneliness of diabetes.Conclusions GSD-Y has, in various ways, mitigated experiences of loneliness and contributed to conscious reflection about self-management in the group (referent power) together with the group leader (expert power). Overall, this highlights the benefits of group education, and the GSD method emphasizes the person-centered approach.
|
|
| 3. |
|
|
| 4. |
- Granström, Therese, 1969-
(författare)
-
Anti-VEGF treatment of patients with diabetic macular edema : Studies of visual acuity, macular edema and patient-reported outcomes
- 2016
-
Licentiatavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The aim of this thesis was to describe and evaluate visual acuity, macular edema and patientreported outcomes (PRO) following anti-VEGF treatment of diabetic macular edema (DME) patients in a real-world setting. Using a longitudinal study design, a cohort of DME patients was followed from baseline to 1 year after treatment start. Data were collected from two eye clinics at two county hospitals. Social background characteristics, medical data and PRO were measured before treatment initiation, at four month and after 1 year. A total of 57 patients completed the study. Mean age was 69 years and the sample was equally distributed regarding sex. At baseline, the patients described their general health as low. One year after treatment initiation, 30 patients had improved visual acuity and 27 patients had no improvement in visual acuity. The patients whose visual acuity improved reported an improvement in several subscales in patient-reported outcome measures (PROM), which was in contrast to the group that experienced a decline in visual acuity, where there was no improvement in PROM. Outcomes from the study can be useful for developing and providing relevant information and support to patients undergoing this treatment.
|
|
| 5. |
- Granström, Therese, 1969-, et al.
(författare)
-
Mentoring model in municipal health care in Dalarna, Sweden : A model for supporting new employeed nurses' professional role in municipal health care
- 2012
-
Ingår i: Ageing connects. - : International Federation on Ageing. Global Conference on Ageing.
-
Konferensbidrag (refereegranskat)abstract
- Background The society and health care units are increasing the demands on nurses. Newly employed nurses are expected to be able to work from the first day of employment independently.Aim That the newly employed nurses in communities within the County of Dalarna, receive support enabling them to feel safe in their professional role and ensure patient safety.The scope of the projectThe Mentor Model (MM) is based on the fact that the municipalities in Dalarna County (n = 15) appoints a Headmentor (HM). The HM is responsible for appointing a mentor (M) for all newly employed nurses and has a supportive function for all mentors. The mentors (M) should have professional experience and are responsible for the newly employed nurses under a period of one year. In order for the M to provide support i.e. time for reflection with the HM and newly employed nurse sufficient, time must be allocated, i.e. two weeks.The (M) should be available to answer necessary, and networking with other mentors in Dalarna.Interviews with HM, M and newly employed in the municipalities showed positive gains with appointing an MM. The positive effects were: patient safety, the nurses felt more confident and the HM and M had opportunity to develop professionally.
|
|
| 6. |
- Granström, Therese, 1969-
(författare)
-
Patient-reported and medical outcomes in patients treated for diabetic macular edema : A real-world longitudinal study
- 2020
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Background Diabetes mellitus can lead to complications, when the complication affects the eyes it is called retinopathy. This can affect the macula and lead to severe loss of vision, diabetic macular edema (DME). This condition has traditionally been treated with laser. However, in 2011, anti-vascular endothelial growth factor (anti-VEGF) injections in the eye were approved as a treatment for diabetic macular edema, and started to be used in eye clinics.Aim The overall aim of this thesis was to describe patient-reported outcomes and medical outcomes (PRO) in people treated for diabetic macular edema in a real-world setting in a long-time follow-up study in Sweden.Methods Participants were enrolled at two eye clinics at two county hospitals in Sweden between 2012 and 2014. Patient-reported outcomes were measured using a vision-specific questionnaire, the 25-question National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and a generic questionnaire, the Short Form-36 Health Survey (SF-36). Completed questionnaires, medical data such as visual acuity (EDRS), macula swelling (OCT) and social background characteristics were collected before treatment start, at one-year and four-year follow up points. The data was analyzed, descriptive statistics developed and comparative analyses were performed. Interviews were performed before treatment start and were analyzed using qualitative content analysis.Results A total of 59 participants were included at baseline. The mean age was 69 years, with an equal gender distribution. At baseline, the participants scored a low general health with the vision-specific questionnaire. In total, 21 participants were interviewed, and a theme emerged of ‘being at a crossroads and a crucial phase in life with an uncertain outcome’. The participants expressed thoughts and concerns at different levels, including practical concerns about the treatment procedure and more existential thoughts about hope for improved visual acuity or fear of deterioration. The results at the one-year follow up showed that 30 patients had improved visual acuity and reported an improvement in several subscales in the NEI VFQ-25. The remaining 27 participants had no improvement in visual acuity or in the vision specific questionnaire. The four-year follow-up involved 37 people, and the result showed significant improvement in subjective near-vision activities and improved distance visual acuity.Conclusion: Before treatment, the participants reported low general health and expressed concerns about the injection treatment and their vision. One year after treatment started, the results showed significant improvement in several NEI VFQ-25 subscales, decreased macula swelling and improved visual acuity. These positive results remained at the four-year follow-up point.
|
|
| 7. |
- Granström, Therese, 1969-
(författare)
-
Patient-reported outcomes and visual acuity in patients after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Aims: To examine objective visual acuity measured with ETDRS, retinal thickness (OCT), and patient reported outcome measurements in patients treated with anti-VEGF treatment for visual impairment due to DME in routine clinical care after 12 months.Methods: In this cross-sectional study, 58 patients (29 females and 29 males; mean age, 68 years) with type 1 and type 2 diabetes diagnosed with macular edema were included. Medical data and two questionnaires were collected; an eye-specific (NEI VFQ-25) and a generic health-related quality of life questionnaire (SF-36) were used after anti-VEGF treatment.Results: Thirty patients had significantly improved visual acuity (p-value ˂ 0.001), and 27 patients had no improved visual acuity at 12 months. Both groups had significantly (p-value ˂ 0.001), reduced retinal thickness (OCT). The patients with improved visual acuity had significantly improved scores for NEI VFQ-25 subscales including general health (p-value ˂ 0.004),, general vision (p-value - 0.001), near activities (p-value- 0.015), distance activities (p-value- 0.008), and composite score (p-value 0.024), but no significant changes in scores were found in the group without improvements in visual acuity.Conclusions: The patient-reported outcome measurements improved in the total patient population. A high HbA1c at baseline may be a risk factor for poor treatment effects.
|
|
| 8. |
|
|
| 9. |
- Granström, Therese, 1969-, et al.
(författare)
-
Quality of life among patients with diabetes macular edema
- 2015
-
Konferensbidrag (refereegranskat)abstract
- Vision loss have a significant negative impact on quality of life. One of the most common causes of vision loss in patients with diabetes is diabetic macular edema - DME. Among DME patients, visual impairment is regarded as the most feared late diabetic complication. In January 2011 a new treatment for DME was approved, called anti-Vascular Endothelial Growth Factor, anti-VEGF- treatment. The treatment involves 3 injections every 4 weeks into the eye. The new treatment places increasing demands on the patient because of more visits and a stressful treatment. Beside that it is of great importance to learn more about the patient's experiences about the visual impairment and the new treatment.The aim of the study is to measure the effects of anti-VEGF treatment on vision related functioning, quality of life and sight-related variables.Fifty-nine patients are included in this longitudinal study at the eye clinics of two Swedish county hospitals. All patients who started anti-VEGF treatment were asked to participate.We have measured visual functioning with the eye-specific questionnaire - National Eye Institute Visual Functioning Questionnaire 25 (NEI-VFQ-25), quality of life was measured with the general questionnaire Short Form- 36 (SF-36). Medical variables were collected at baseline, after 4 months and one year respectively.A large number of patients are affected by diabetes each year and may suffer from visual impairment. These patients may be treated with this new form of treatment. Therefore it is of great importance to examine the patient's experiences of treatment and self-percieved quality of life to be able to provide the best possible information and procedures at the eye clinics.
|
|
| 10. |
- Granström, Therese, 1969-, et al.
(författare)
-
Visual functioning and quality of life among patients with diabetic macular edema
- 2015
-
Konferensbidrag (refereegranskat)abstract
- BackgroundOne of the most common causes of vision impairment in patients with diabetes is diabetic macular edema (DME) and is regarded as the most feared late diabetic complication. In January 2011 a treatment for DME was approved, called anti-Vascular Endothelial Growth Factor treatment. The treatment involves an injection into the vitreous of the eye and places increasing demands on the patient because of more visits and a stressful treatment. Therefore it is of most importance to capturing patients’ thoughts and feelings, so called Patient reported Outcome (PRO).AimTo examine patient-reported outcome (PRO) in a selected group of Swedish patients with diabetes-related macula edema about to receive anti-vascular endothelial growth factor treatment for diabetic macular edema.MethodVisual functioning was measured with National Eye Institute Visual Functioning Questionnaire 25 (NEI-VFQ-25), quality of life was measured with Short Form- 36 (SF-36). The initial eye examination included measurement of visual acuity with the ETDRS, and retinal thickness by OCT. In addition, medical variables were collected. The data collection was performed at baseline, after 4 months and one year. In this abstract we reported the result from the baseline.ResultThe participants were 30 men and 29 women (mean age, 68.5 years) and 92% of them had type 2 diabetes. With NEI VFQ-25, the participants showed the lowest score for the subscale of general health (mean 35.65 ± 22.04) and the highest for dependency (mean 93.48 ± 18.12). For SF-36, the participants gave the lowest score in the subscale of general health (mean 56.55 ± 22.14) and the highest for the subscale of role emotional (mean 88.73 ± 22.32). The mean ETDRS score in the eye planned for treatment was 63.9 (± 13.2) and the mean central retinal thickness was 396 (± 129).Conclusions: Patients diagnosed with diabetes macula edema about to receive anti-VEGF treatment reported low general health. Hence, it is of most importance to follow up patients’ thoughts and feelings (PRO) after the treatment is performed in order to promote improvements in the quality of patient care.
|
|
